Shayida Maimaiti1,2, Ryusuke Koshida3, Masami Ojima1, Kaushalya Kulathunga1,4, Hisashi Oishi5, Satoru Takahashi1. 1. Department of Anatomy and Embryology, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan. 2. Present address: Okinawa Institute of Science and Technology Graduate University, 1919-1 Tancha, Onna-son, Okinawa 904-0412, Japan. 3. Department of Anatomy and Neuroscience, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan. 4. Ph.D. Program in Human Biology, School of Integrative and Global Majors, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan. 5. Department of Comparative and Experimental Medicine, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi 467-8601, Japan.
Abstract
Mammalian postnatal growth is regulated primarily by the growth hormone (GH)/insulin-like growth factor I (IGF-I) axis. MafB is a basic leucine zipper (bZip) transcription factor that has pleiotropic functions. Although MafB plays a critical role in fetal brain development, such as in guidance for hindbrain segmentation, its postnatal role in neurons remains to be elucidated. To investigate this, we used neuron-specific Mafb conditional knockout (cKO) mice. In addition to an approximately 50% neonatal viability, the Mafb cKO mice exhibited growth retardation without apparent signs of low energy intake. Notably, serum IGF-I levels of these mice in the postnatal stage were lower than those of control mice. They seemed to have a neuroendocrine dysregulation, as shown by the upregulation of serum GH levels in the resting state and an inconsistent secretory response of GH upon administration of growth hormone-releasing hormone. These findings reveal that neuronal MafB plays an important role in postnatal development regulated by the GH/IGF-I axis.
Mammalian postnatal growth is regulated primarily by the growth hormone (GH)/insulin-like growth factor I (IGF-I) axis. MafB is a basic leucine zipper (bZip) transcription factor that has pleiotropic functions. Although MafB plays a critical role in fetal brain development, such as in guidance for hindbrain segmentation, its postnatal role in neurons remains to be elucidated. To investigate this, we used neuron-specific Mafb conditional knockout (cKO) mice. In addition to an approximately 50% neonatal viability, the Mafb cKO mice exhibited growth retardation without apparent signs of low energy intake. Notably, serum IGF-I levels of these mice in the postnatal stage were lower than those of control mice. They seemed to have a neuroendocrine dysregulation, as shown by the upregulation of serum GH levels in the resting state and an inconsistent secretory response of GH upon administration of growth hormone-releasing hormone. These findings reveal that neuronal MafB plays an important role in postnatal development regulated by the GH/IGF-I axis.
Mammalian postnatal growth is regulated primarily by the growth hormone (GH)/insulin-like
growth factor I (IGF-I) axis [20]. GH is secreted
from somatotrophic cells in the anterior pituitary glands in a pulsatile manner regulated by
hypothalamicgrowth hormone-releasing hormone (GHRH). In addition, GH secretion is enhanced
by ghrelin and inhibited by somatostatin. GH induces hepatic IGF-I secretion that plays a
crucial role in promoting linear skeletal growth during childhood [31]. In addition to regulation by GH, circulating IGF-I is affected by
nutritional status, namely, low energy intake or protein deficiency that can suppress
hepatic IGF-I secretion [6, 12]. Additionally, proteolytic enzymes attack certain conformations of
circulating IGF-I, as evidenced by the lower half-life (a few minutes) of free IGF-I versus
the stabilized complex (more than 10 h) that contains IGF binding protein 3 (IGFBP3) [1] and the acid-labile subunit (ALS) [29].MafB is a basic leucine zipper (bZip) transcription factor that belongs to the large Maf
family, whose proteins commonly bind to a consensus DNA sequence referred to as the Maf
recognition element (MARE) [5]. MafB plays a crucial
role in fetal development of several organs such as the kidneys [21], inner ear [4], pancreatic
islets [8], and parathyroid glands [15]. MafB also plays a role in maintenance of adult
tissues through transcription of key molecules such as glucagon [16], parathyroid hormone [23],
nephrin, and podocin [22, 27].MafB is diffusely expressed in the developing brain [3, 19]. Earlier studies using
Kreisler mice carrying Mafb mutations have revealed that
it guides hindbrain segmentation in the early embryonic stage [4]. MafB is also essential for development of the pre-Bötzinger complex in
the medulla oblongata, which is responsible for respiratory rhythmogenesis [2]. However, the postnatal role of MafB in neurons remains
to be elucidated.Here, we have generated neuron-specific Mafb conditional knockout (cKO)
mice. Approximately half of the Mafb cKO mice died within 48 h after birth,
and the survivors exhibited growth retardation. There was no evidence of low energy intake
in these mice, but GH/IGF-Iaxis impairment was observed. Our study reveals that the
function of MafB in neurons is important for postnatal growth regulated by the GH/IGF-I
axis.
Materials and Methods
Mice
Mafb/ mice in
which loxP sites flank exon 1 of the Mafb gene [28], Mafb-deficient
(Mafb) mice in which the GFP gene is knocked-in in the
Mafb locus [21], and R26GRR mice
in which a switch of constitutive expression from GFP to tdsRed is induced by Cre-mediated
recombination in the ROSA locus [11] were described
previously. Nes-Cre mice, neuron-specific Cre driver mice [13], were kindly provided from by R. Kageyama (Kyoto University). All mice were
maintained on the C57BL/6J background. The pups were weaned at 3 weeks of age. All
experiments were performed according to the Guide for the Care and Use of Laboratory
Animals at the University of Tsukuba.
Brain sections and immunohistochemistry
Mice at embryonic day 12.5 (E12.5) and postnatal day 0 (P0) were fixed with
paraformaldehyde (PFA) in PBS at 4°C overnight. Next, whole embryos and brains at P0 were
cryoprotected in 30% sucrose and embedded in Tissue-Tek OCT compound (Sakura Finetek,
Tokyo, Japan). Frozen sections were prepared at a thickness of 20 µm
using a cryostat. For immunohistochemistry, sections were blocked with 10% normal goat
serum plus 0.3% Triton X-100 in PBS for 1 h at room temperature. The sections were
incubated with anti-MafB antibody (1:500, IHC-00351, Bethyl Laboratories, Montgomery, TX,
USA) overnight at 4°C. After washing, slides were incubated with Alexa Fluor
594-conjugated secondary antibody (Molecular Probes, Eugene, OR, USA) for 1 h at room
temperature. Fluorescent images were acquired using a Biorevo BZ-9000 fluorescence
microscope (Keyence, Osaka, Japan). For assessment of efficiency of Cre-mediated
recombination, 4 sections were prepared from each sample, and tdsRed-positive areas were
measured with ImageJ software (NIH, Bethesda, MD, USA).
Measurements of blood glucose and serum IGF-I
Blood was collected by cardiac puncture, and glucose concentration was immediately
measured with a Medisafe glucometer (Terumo, Tokyo, Japan). After clotting, blood was
centrifuged at 3,000 g for 10 min, and the resultant supernatant was collected. Serum
IGF-I concentration was measured with a Mouse/RatIGF-I Quantikine ELISA kit (MG100,
R&D systems, Minneapolis, MN, USA).
GHRH administration and GH measurement
Mice at 4 weeks of age were injected intraperitoneally with 5 µg of
humanGHRH (GHRH-288H, Creative Biomart, Shirley, NY, USA). Blood was repeatedly collected
through a facial vein before and 5 min after GHRH administration. To minimize the effect
of diurnal variation of GH, the experiments were performed between 9 a.m. and 11 a.m.
Serum GH concentration was measured with a Rat/MouseGH ELISA (EZRHGH-45K, MilliporeSigma,
Burlington, MA, USA).
Quantitative RT-PCR
Total RNA was extracted from snap-frozen livers at P14 with Isogen (Nippon Gene, Tokyo,
Japan), and cDNA was synthesized with a QuantiTect Reverse Transcription kit (QIAGEN,
Hilden, Germany), each according to manufacturers’ instructions. Real-time PCR was run on
a Thermal Cycler Dice Real Time System Single (Takara, Shiga, Japan) with SYBR Green PCR
master mix (Takara). The primer sequences used were as follows: Pck1
forward, 5’-CACCATCACCTCCTGGAAGA-3’; Pck1 reverse,
5’-GGGTGCAGAATCTCGAGTTG-3’; G6pc forward, 5’-CGACTCGCTATCTCCAAGTGA-3’;
G6pc reverse, 5’-GTTGAACCAGTCTCCGACCA-3’; Fgf21
forward, 5’-GTGTCAAAGCCTCTAGGTTTCTT-3’; Fgf21 reverse,
5’-GGTACACATTGTAACCGTCCTC-3’; Hprt forward,
5’-TTGTTGTTGGATATGCCCTTGACTA-3’; Hprt reverse,
5’-AGGCAGATGGCCACAGGACTA-3’. All PCR was performed duplicates in all cases, and
amplification products were quantified by the standard curve method. The mRNA levels of
each gene were normalized to Hprt.
Statistical analysis
Data are expressed as means ± SEMs. Differences between the two groups were analyzed
using a Student t-test or a Wilcoxon rank-sum test. For intraindividual
comparison, a paired t-test was applied. For comparison of survival rate,
a Fisher exact test was applied. For multiple comparisons, a Tukey honest significant
differences (HSD) test or a Bonferroni correction was applied. All statistical analyses
were performed with R software (http://www.r-project.org). Probability values of less than
0.05 were considered significant.
Results
Neuron-specific deletion of the Mafb gene causes neonatal death
To delete the Mafb gene specifically in the neural lineage using a
Cre-loxP strategy, we chose a line of Nes-Cre mice [13]. Given that spatiotemporal validity of Nes-Cre mice
has been argued [14, 17], we initially evaluated the recombination efficiency of the Nes-Cre
mice by crossing with GRR26R mice, reporter mice in which cells are labeled with tdsRed by
Cre-mediated recombination [11] (Nes-Cre;R26GRR
mice). We found that recombination-induced tdsRed expression is incomplete in the brains
at E12.5, particularly in the cerebral cortex and tectum of the midbrain (Fig. 1A). At P0, tdsRed-positive areas covered more than 90% of the brain parenchyma of the
Nes-Cre;R26GRR mice (Fig. 1B, D). We also
analyzed MafB expression using Mafb/+ mice
[21] and confirmed that MafB is already expressed
in the hindbrain at E12.5 (Fig. 1C). These
results imply that residual activity of MafB in embryonic neurons may have some effects on
the phenotype of the Mafb cKO mice.
Fig. 1.
Neuron-specific deletion of Mafb gene causes neonatal death.
Parasagittal images of the Nes-Cre;R26GRR brains at E12.5 (A) and P0 (B) and of the
Mafb/+ brain at E12.5 (C). (A, B)
tdsRed (red) and GFP (green) indicate areas with and without Cre-mediated
recombination, respectively. Te, telencephalon; De, diencephalon; MB, midbrain; HB,
hindbrain. Scale bars: 1 mm. (C) The GFP signals, which recapitulate endogenous MafB
expression, are obviously observed in the hindbrain (arrow) and the hindbrain
choroid plexus (hChP). Scale bar: 1 mm. (D) Percentage of tdsRed-positive areas in
the different brain regions of the Nes-Cre;R26GRR mice at E12.5 and P0. n=3 per
group. (E) Immunohistochemical staining of MafB in the cerebral cortices at P0. MafB
immunoreactivity (red) is absent in the “MafB-positive” neurons (green) of
Nes-Cre;Mafb/
pups (lower panel). Scale bar: 100 µm. (F) Neonatal outcome at 48 h
after birth. ***P<0.001, Fisher exact test.
Neuron-specific deletion of Mafb gene causes neonatal death.
Parasagittal images of the Nes-Cre;R26GRR brains at E12.5 (A) and P0 (B) and of the
Mafb/+ brain at E12.5 (C). (A, B)
tdsRed (red) and GFP (green) indicate areas with and without Cre-mediated
recombination, respectively. Te, telencephalon; De, diencephalon; MB, midbrain; HB,
hindbrain. Scale bars: 1 mm. (C) The GFP signals, which recapitulate endogenous MafB
expression, are obviously observed in the hindbrain (arrow) and the hindbrain
choroid plexus (hChP). Scale bar: 1 mm. (D) Percentage of tdsRed-positive areas in
the different brain regions of the Nes-Cre;R26GRR mice at E12.5 and P0. n=3 per
group. (E) Immunohistochemical staining of MafB in the cerebral cortices at P0. MafB
immunoreactivity (red) is absent in the “MafB-positive” neurons (green) of
Nes-Cre;Mafb/
pups (lower panel). Scale bar: 100 µm. (F) Neonatal outcome at 48 h
after birth. ***P<0.001, Fisher exact test.Next, we generated neuron-specific Mafb cKO mice by crossing the Nes-Cre
mice with Mafb/
mice [28]
(Nes-Cre;Mafb/
mice). Furthermore, we performed immunohistochemistry for MafB using
Nes-Cre;Mafb/GFP mice and
confirmed successful deletion of MafB protein in GFP-positive (“MafB-positive”) cortical
neurons at P0 (Fig. 1E).Whole-body deletion of the Mafb gene leads to 100% neonatal death due to
respiratory arrest associated with abnormalities in fetal brain development [2]. Within 48 h after birth, 48% (12 out of 25) of the
Mafb cKO mice pups died, which is far higher compared with the 4% (1
out of 26) of the
Mafb/ pups
(Fig. 1F). This result reinforces the idea
that MafB plays an important role in neural development that facilitates perinatal
survival.
We monitored postnatal growth of the surviving Mafb cKO mice. On the day
of birth, no significant difference in body weight was observed between the
Mafb cKO and two control
(Nes-Cre;Mafb/+ and
Mafb/) mice
(Fig. 2A). At the postnatal stage, however, weight gain in Mafb cKO mice
was stunted compared with the control mice (Figs.
2A and B). After weaning, the Mafb cKO mice started to catch up
with the control mice (Fig. 2C), resulting in a
marginal difference in body weight among genotypes at 12 weeks of age (Fig. 2D).
Fig. 2.
Neuron-specific Mafb cKO mice exhibit growth retardation. (A) Body
weight during the postnatal stage in each genotype. n=5–15 per group.
**P<0.01, Tukey honest significant differences (HSD) test.
***P<0.001, Tukey HSD test. N.S., not significant. (B) P7 pups
of Mafb/
(left) and
Nes-Cre;Mafb/
(right). (C) Growth curves after weaning of male (left) and female (right) mice.
n=10–15 per group. (D) Differences in body weight between genotypes at 12 weeks of
age. *P<0.05, Tukey HSD test. **P<0.01,
Tukey HSD test.
Neuron-specific Mafb cKO mice exhibit growth retardation. (A) Body
weight during the postnatal stage in each genotype. n=5–15 per group.
**P<0.01, Tukey honest significant differences (HSD) test.
***P<0.001, Tukey HSD test. N.S., not significant. (B) P7 pups
of Mafb/
(left) and
Nes-Cre;Mafb/
(right). (C) Growth curves after weaning of male (left) and female (right) mice.
n=10–15 per group. (D) Differences in body weight between genotypes at 12 weeks of
age. *P<0.05, Tukey HSD test. **P<0.01,
Tukey HSD test.
Neuron-specific Mafb cKO mice exhibit no signs of low energy intake in the postnatal
stage
Since low energy intake as a result of poor suckling could be a cause of growth
retardation, we investigated the nutritional status of
Nes-Cre;Mafb/
mice. Blood glucose levels in the Mafb cKO mice were comparable to those
of Mafb/ mice
(Fig. 3A). To further test the possibility that activated gluconeogenesis compensates for
low energy intake [18], we examined expression
levels of gluconeogenesis-related genes (Pck1, G6pc, and
Fgf21) in the liver. The qRT-PCR experiments did not show any
significant differences in these genes. (Fig.
3B). According to these results, the Mafb cKO mice exhibited no
signs of low energy intake.
Fig. 3.
Neuron-specific Mafb cKO mice exhibit no signs of low energy
intake in the postnatal stage. (A) Blood glucose levels at P14. n=11
(Mafb/)
and 9
(Nes-Cre;Mafb/).
Red lines represent means ± SEMs. No significant difference is found between
genotypes (Student t-test). (B) Quantitative RT-PCR analysis does
not show upregulation of gluconeogenesis-related genes (Pck1, G6pc,
Fgf21) in the livers of
Nes-Cre;Mafb/
mice at P14 (Student t-test). n=4 per group.
Neuron-specific Mafb cKO mice exhibit no signs of low energy
intake in the postnatal stage. (A) Blood glucose levels at P14. n=11
(Mafb/)
and 9
(Nes-Cre;Mafb/).
Red lines represent means ± SEMs. No significant difference is found between
genotypes (Student t-test). (B) Quantitative RT-PCR analysis does
not show upregulation of gluconeogenesis-related genes (Pck1, G6pc,
Fgf21) in the livers of
Nes-Cre;Mafb/
mice at P14 (Student t-test). n=4 per group.
The GH/IGF-I axis is impaired in neuron-specific Mafb cKO mice
To identify the cause of growth retardation in the Mafb cKO mice, we
measured circulating levels of GH and IGF-I that critically regulate body size [31]. Notably, serum IGF-I levels in the
Mafb cKO mice were significantly lower than those in the
Mafb/ mice
(Fig. 4A). We further investigated GH secretory capacity from the anterior pituitary gland
in response to GHRH administration and found that, in the basal state, serum GH levels in
the Mafb cKO mice were significantly higher than those in
Mafb/ mice.
Upon administration of GHRH,
Mafb/ mice
consistently exhibited enhanced GH secretion while the Mafb cKO mice had
an inconsistent response to GHRH (Fig. 4B).
Fig. 4.
The growth hormone (GH)/insulin-like growth factor I (IGF-I) axis is impaired in
neuron-specific Mafb cKO mice. (A) Serum IGF-I levels at 4 weeks of
age. n=10 per group. ***P<0.001, Student
t-test. (B) Serum GH levels before and 5 min after intraperitoneal
administration of growth hormone-releasing hormone (GHRH) (5 µg) at
4 weeks of age. n=8
(Mafb/)
and 9
(Nes-Cre;Mafb/).
*P<0.05, paired t-test (0 min vs. 5 min) or
Wilcoxon rank sum test
(Mafb/
vs.
Nes-Cre;Mafb/)
adjusted by Bonferroni correction. N.S., not significant. Red lines represent means
± SEMs.
The growth hormone (GH)/insulin-like growth factor I (IGF-I) axis is impaired in
neuron-specific Mafb cKO mice. (A) Serum IGF-I levels at 4 weeks of
age. n=10 per group. ***P<0.001, Student
t-test. (B) Serum GH levels before and 5 min after intraperitoneal
administration of growth hormone-releasing hormone (GHRH) (5 µg) at
4 weeks of age. n=8
(Mafb/)
and 9
(Nes-Cre;Mafb/).
*P<0.05, paired t-test (0 min vs. 5 min) or
Wilcoxon rank sum test
(Mafb/
vs.
Nes-Cre;Mafb/)
adjusted by Bonferroni correction. N.S., not significant. Red lines represent means
± SEMs.
Discussion
In the present study, we generated and analyzed neuron-specific Mafb cKO
mice. We found that half of these mice die within 48 h after birth and that the surviving
pups exhibit stunted growth. Analysis of blood glucose and gene expression related to
gluconeogenesis did not indicate any low energy intake; however, serum IGF-I levels of the
Mafb cKO mice were lower than those of control mice. Conversely, we found
that serum GH levels (upstream of IGF-I) were upregulated at rest in the
Mafb cKO mice but that GHRH-induced GH secretion in these mice was
inconsistent. Collectively, our findings reveal that neuronal MafB plays an important role
in postnatal development.Whole-body deletion of Mafb gene causes 100% neonatal death by respiratory
arrest, which may be attributed to abnormal development of the pre-Bötzinger complex in the
medulla oblongata [2]. In our study, the neonatal
mortality rate of the Mafb cKO pups was approximately 50%. Although we did
not examine the respiratory activity of these mice, it is likely that their respiratory
rhythmogenesis after birth is impaired due to lack of neuronal MafB. Given the results of
our histological analysis using Nes-Cre;R26GRR mice, the reduction of mortality rate may be
attributed to incomplete deletion of neuronal MafB in the early embryonic stage. Our results
do reinforce the idea that MafB in the developing neurons plays a critical role in preparing
neonates for adaptation to the postnatal environment.Although the surviving Mafb cKO pups exhibit growth retardation, it should
be noted that a Nes-Cre transgene per se may cause problems with the growth of transgenic
mice. In fact, the Nes-Cre mouse line from the Jackson Laboratory (No. 003771,
https://www.jax.org/strain/003771) has metabolic and endocrine phenotypes including lower
production of anterior pituitary hormones such as GH and thyroid stimulating hormone (TSH)
[7, 9]. In our
study, Nes-Cre;Mafb/+ mice were comparable in
body weight to
Mafb/ mice, and
moreover, the Mafb cKO mice were significantly smaller than either of these
two mice. Therefore, it is safe to say that this Nes-Cre transgene [13] does not account for the growth retardation of the
Mafb cKO mice.To probe the phenotype of Mafb cKO mice, we analyzed nutritional status,
as it is critical for postnatal growth, and abnormal brain development is often accompanied
by poor suckling [26]. Although ingested milk amounts
are quite difficult to measure, activation of gluconeogenesis can serve as a biomarker for
low energy intake [18]. However, gluconeogenesis
upregulation was not observed in our study.Given that the GH/IGF-I axis is critical for postnatal growth [31], reduction of circulating IGF-I is most likely a cause of growth
retardation in the Mafb cKO mice. We also found that basal GH levels are
elevated in the Mafb cKO mice, which is probably due to attenuated negative
feedback from IGF-I to somatotrophic cells in the pituitary [6]. In addition to indirect effects via IGF-I, GH has a direct effect on promoting
longitudinal skeletal growth independently of IGF-I [30]. Thus, upregulation of basal GH levels may contribute to the growth of the
Mafb cKO mice catching up after weaning. Furthermore, inconsistent GH
secretion in response to GHRH, which is indicative of neuroendocrine dysregulation, was
observed in the Mafb cKO mice. However, it remains unknown how
neuron-specific Mafb deletion results in the reduction of circulating
IGF-I. Region- or cell-type-specific Cre drivers [10]
would be helpful in solving this remaining issue.MAFB mutations in humans cause either multicentric carpotarsal osteolysis
(MCTO [MIM 166300]) [24, 32] or a subset of Duane retraction syndrome (DRS [MIM 126800]) [25, 27] depending
on the affected site. MCTO is characterized by childhood-onset arthritis, and DRS is
characterized by congenital disorders of outward eye movement; both diseases are often
accompanied by progressive nephropathy leading to end-stage renal disease. Unfortunately,
neither postnatal skeletal growth nor blood concentrations of GH or IGF-I have been
described in previous reports of these MAFB mutation-mediated diseases. Our
results may therefore be an important first look at hidden dysregulation in the GH/IGF-I
axis within MAFB-mediated diseases.In summary, our study using neuron-specific Mafb cKO mice revealed that
MafB in neurons plays an important role for postnatal growth regulated by the GH/IGF-I
axis.
Authors: Steven Mumm; Margaret Huskey; Shenghui Duan; Deborah Wenkert; Katherine L Madson; Gary S Gottesman; Angela R Nenninger; Ronald M Laxer; William H McAlister; Michael P Whyte Journal: Am J Med Genet A Date: 2014-07-02 Impact factor: 2.802
Authors: Jong G Park; Max A Tischfield; Alicia A Nugent; Long Cheng; Silvio Alessandro Di Gioia; Wai-Man Chan; Gail Maconachie; Thomas M Bosley; C Gail Summers; David G Hunter; Caroline D Robson; Irene Gottlob; Elizabeth C Engle Journal: Am J Hum Genet Date: 2016-05-12 Impact factor: 11.025
Authors: Lynette Lim; Janelle M P Pakan; Martijn M Selten; André Marques-Smith; Alfredo Llorca; Sung Eun Bae; Nathalie L Rochefort; Oscar Marín Journal: Nat Neurosci Date: 2018-06-18 Impact factor: 24.884
Authors: Ruizhi Deng; Kristina Lanko; Eva Medico Salsench; Anita Nikoncuk; Soheil Yousefi; Herma C van der Linde; Elena Perenthaler; Tjakko J van Ham; Eskeatnaf Mulugeta; Tahsin Stefan Barakat Journal: Genome Med Date: 2021-10-19 Impact factor: 11.117